News and Trends 11 Jul 2023
NodThera first to show reduction in neuroinflammation with inflammasome inhibitor
NodThera has announced positive, initial data from four subjects in the elderly volunteer stage of its phase Ib/IIa study evaluating the effects of its lead candidate NT-0796 on inflammatory and…